Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Comment by fairweather1on Oct 21, 2013 6:47am
87 Views
Post# 21832430

RE:Why isn't the GM lawsuit collection priced in?

RE:Why isn't the GM lawsuit collection priced in?
It looks to me like the market is following liquidation value day by day.  By my calculations, if they were to liquidate today, you'd be looking at a NAV below current share price.  So there is actually a super conservative premium built in right now.

Something very bad/bizarre would have to happen between now and the conclusion of Ford contract to not eclipse this price by a good margin, but I also think it not prudent to put any value on the GM settlement until it actually happens.  I saw a post on this board suggesting that the big Ford extension was a "slam dunk", and the share price of over $3 at the time showed that this view was shared by others.  Did not happen!

I am optimistic of some measure of compensation from GM, but I'm not holding my breath or putting a value on it at this point. I simply think that based on the ford contract alone, this is a very safe investment at current SP.
Bullboard Posts